Renaissance Technologies JAZZ PHARMACEUTICALS PLC ownership

JAZZ PHARMACEUTICALS PLC's ticker is JAZZ and the CUSIP is G50871105. A total of 455 filers reported holding JAZZ PHARMACEUTICALS PLC in Q3 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.

Renaissance Technologies ownership history of JAZZ PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2022$173,078
-22.2%
1,298,509
-8.9%
0.24%
-6.8%
Q2 2022$222,487
-5.8%
1,426,109
-6.0%
0.26%
-5.1%
Q1 2022$236,199
+9.0%
1,517,309
-10.8%
0.28%
+2.6%
Q4 2021$216,645
-16.8%
1,700,509
-14.9%
0.27%
-19.6%
Q3 2021$260,291
-36.8%
1,999,009
-13.7%
0.34%
-34.6%
Q2 2021$411,635
-5.9%
2,317,240
-13.0%
0.51%
-5.5%
Q1 2021$437,660
-14.4%
2,662,650
-14.1%
0.54%
-2.0%
Q4 2020$511,498
+7.6%
3,099,050
-7.1%
0.56%
+16.8%
Q3 2020$475,531
+23.9%
3,334,950
-4.1%
0.48%
+43.5%
Q2 2020$383,786
+11.9%
3,478,213
+1.2%
0.33%
-0.6%
Q1 2020$342,961
-35.3%
3,438,550
-3.1%
0.33%
-18.2%
Q4 2019$529,850
+32.6%
3,549,371
+13.8%
0.41%
+20.4%
Q3 2019$399,502
+9.6%
3,117,701
+22.0%
0.34%
+5.3%
Q2 2019$364,355
+27.9%
2,555,801
+28.2%
0.32%
+23.9%
Q1 2019$284,914
+99.8%
1,993,101
+73.3%
0.26%
+66.0%
Q4 2018$142,579
-5.3%
1,150,201
+28.4%
0.16%
+0.6%
Q3 2018$150,610
-47.7%
895,794
-50.0%
0.16%
-1.3%
Q2 2018$288,200
+99.2%
1,791,200
+86.9%
0.16%
-0.6%
Q1 2018$144,709
-13.7%
958,400
-23.0%
0.16%
-14.6%
Q4 2017$167,612
-5.8%
1,244,800
+2.4%
0.18%
-11.5%
Q3 2017$177,855
-4.8%
1,216,100
+1.2%
0.21%
-12.2%
Q2 2017$186,833
+10.9%
1,201,500
+3.5%
0.24%
+1.3%
Q1 2017$168,491
-1.0%
1,160,963
-25.6%
0.24%
-12.6%
Q4 2016$170,120
+53.1%
1,560,300
+70.6%
0.27%
+37.2%
Q3 2016$111,130
+9.3%
914,800
+27.1%
0.20%
+1.0%
Q2 2016$101,674
+262.1%
719,508
+234.5%
0.19%
+266.0%
Q1 2016$28,081
+962.5%
215,100
+1044.1%
0.05%
+783.3%
Q4 2015$2,643
-84.0%
18,800
-84.9%
0.01%
-84.6%
Q3 2015$16,508
+412.4%
124,300
+579.2%
0.04%
+457.1%
Q2 2015$3,222
+95.6%
18,300
+63.4%
0.01%
+75.0%
Q2 2014$1,647
-78.3%
11,200
-79.6%
0.00%
-77.8%
Q1 2014$7,599
-24.7%
54,793
-62.7%
0.02%
-30.8%
Q2 2013$10,090146,8000.03%